WisdomTree US Equity Income ETF
23,55
EUR
+0,59
EUR
+2,57
%
20,50
GBP
-1,13
GBP
-5,23
%
Werbung
Werbung
| Emittent | WisdomTree Management |
| Auflagedatum | 02.11.2016 |
| Kategorie | Aktien |
| Fondswährung | GBP |
| Benchmark | WisdomTree US Equity Income UCITS |
| Ausschüttungsart | Thesaurierend |
| Total Expense Ratio (TER) | 0,35 % |
| Fondsgröße | 110.812.485,63 |
| Replikationsart | Physisch optimiert |
| Morningstar Rating | - |
Anlageziel WisdomTree US Equity Income UCITS ETF - GBP Hedged Acc
So investiert der WisdomTree US Equity Income UCITS ETF - GBP Hedged Acc: The Fund seeks to track the price and yield performance, before fees and expenses, of an index that measures the performance of US securities. In order to achieve this objective, the Fund will employ a "passive management" (or indexing) investment approach and will invest in a portfolio of equity securities that so far as possible and practicable consists of a representative sample of the component securities of the WisdomTree US Equity Income UCITS Index (the “Index”).
Der WisdomTree US Equity Income UCITS ETF - GBP Hedged Acc gehört zur Kategorie "Aktien".
Wertentwicklung (NAV) WKN: A2DH1W
| 3 Monate | 6 Monate | 1 Jahr | 3 Jahre | 5 Jahre | 2025 | |
|---|---|---|---|---|---|---|
| Performance | -5,05 % | -4,86 % | +5,14 % | +4,36 % | +70,49 % | -5,26 % |
| Outperformance ggü. Kategorie | +2,51 % | +3,10 % | +8,64 % | +2,06 % | +18,95 % | +3,80 % |
| Max Verlust | - | - | -7,95 % | -26,25 % | -26,25 % | - |
| Kurs | 25,52 £ | 25,31 £ | 22,70 £ | 23,47 £ | 13,82 £ | 20,50 £ |
| Hoch | - | - | 23,19 £ | - | - | - |
| Tief | - | - | 18,68 £ | - | - | - |
Kennzahlen ISIN: IE00BD6RZZ53
| Name | 1 Jahr | 3 Jahre | 5 Jahre | 10 Jahre |
|---|---|---|---|---|
| Volatilität | 13,99 % | 17,07 % | 15,96 % | |
| Sharpe Ratio | +0,62 | +0,13 | +0,74 |
Werbung
Werbung
Zusammensetzung WKN: A2DH1W
Größte Positionen ISIN: IE00BD6RZZ53
| Name | ISIN | Marktkapitalisierung | Gewichtung |
|---|---|---|---|
| AbbVie Inc | US00287Y1091 | 300.823.353.692 € | 5,94 % |
| Exxon Mobil Corp | US30231G1022 | 407.175.088.058 € | 5,30 % |
| Johnson & Johnson | US4781601046 | 330.876.578.851 € | 5,27 % |
| PepsiCo Inc | US7134481081 | 178.995.331.723 € | 4,70 % |
| AT&T Inc | US00206R1023 | 175.561.138.924 € | 4,42 % |
| Chevron Corp | US1667641005 | 223.539.888.788 € | 3,96 % |
| Gilead Sciences Inc | US3755581036 | 119.912.851.048 € | 3,38 % |
| Merck & Co Inc | US58933Y1055 | 186.931.565.360 € | 3,25 % |
| International Business Machines Corp | US4592001014 | 190.845.638.943 € | 3,14 % |
| Amgen Inc | US0311621009 | 141.862.275.706 € | 2,61 % |
| Summe Top 10 | 41,97 % | ||